$PHR

Phreesia, Inc. (PHR): Submission of Matters to a Vote of Security Holders

Phreesia, Inc. (PHR) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. phr-20260624 false 0001412408 0001412408 2026-06-24 2026-06-24 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________ FORM 8-K ___________________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities

Original reporting
Published Jun 24, 2026, 8:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 24, 2026, 8:09 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$PHR
Neutral
high confidence
Mentioned
$PHR
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$PHRNeutralLow
01

Why it matters

The disclosure confirms shareholder approval/ratification outcomes (two director elections, KPMG LLP appointment for FY ending Jan. 31, 2027, and non-binding advisory say-on-pay). It does not introduce new strategy, financial targets, or regulatory/legal developments.

02

Market read

Primarily a governance/proxy mechanics update; not a catalyst for earnings, guidance, or corporate actions.

03

What to watch

Traders should verify whether the proxy statement contained any contested items; this 8-K itself only provides vote counts, not new governance decisions.

Relevance 6/10Novelty 2/10Timing: after-hours/filing update from the June 24, 2026 annual meeting

Background

The SEC 8-K (Item 5.07) summarizes matters submitted to a vote of security holders at Phreesia’s June 24, 2026 annual meeting, referencing the May 14, 2026 proxy statement.

Company-level read

Ticker impact

$PHRNeutralHigh confidence
Context

Phreesia filed an 8-K reporting final shareholder vote results on director elections, KPMG ratification, and advisory executive compensation.

Expected impact

Limited near-term impact; any reaction likely confined to low-liquidity sentiment rather than fundamentals.

Evidence & confidence

The filing is procedural (Item 5.07) and only reports vote tallies for previously disclosed proxy proposals, with no new operational or financial datapoints.

Market effects

None; this is company-specific proxy/voting mechanics.

None indicated.

None indicated.

Counterpoint

If governance outcomes were unexpectedly close, it could briefly affect sentiment around board/compensation, but the filing provides no qualitative dispute or change.

Key entities

  • Phreesia, Inc.

    Subject of the SEC 8-K; reported annual meeting voting results for directors, auditor ratification, and advisory executive compensation.

  • KPMG LLP

    Ratified by shareholders as independent registered public accounting firm for fiscal year ending January 31, 2027.

  • Chaim Indig

    Elected Class I director (votes for/withheld and broker non-votes reported).

  • Jon Kessler

    Elected Class I director (votes for/withheld and broker non-votes reported).

  • Balaji Gandhi

    CFO who signed the 8-K.

Related articles

$PHRMed

Phreesia’s (PHR) Profit Turnaround Meets A Cash-Strapped Client Base

Phreesia (PHR) reported Q2 2027 revenue of $129.5M and adjusted EBITDA of $32.9M, marking five straight quarters of positive net income. Revenue grew 10% YoY, with client count and revenue per client also increasing. The company reduced debt by $23M and credited AI for operational efficiencies. However, management warned of increased unpredictability in network solutions revenue due to financial strain on healthcare providers. Phreesia reaffirmed its full-year revenue and EBITDA guidance.

$PHRHighAI 8/10

Phreesia (PHR) Q2 2027 Earnings Call Transcript

Phreesia (PHR) reported Q2 2027 revenue of $129.5M, up 10% YoY, with adjusted EBITDA of $32.9M and net income of $1.9M. AHSCs grew 6% to 4,744. Full-year guidance: revenue $510M-$520M, adjusted EBITDA $125M-$135M. Management noted variability in revenue forecasting and economic pressures on healthcare providers.

$PHRMed

Why Phreesia Stock Got Knocked Down Today

Phreesia (PHR) stock fell 7% Tuesday due to bearish sentiment after Q2 earnings and a downgrade by Raymond James analyst John Ransom. Ransom cited declining organic revenue growth and AI spending pressures. Despite a 10% revenue increase, concerns remain about future performance and market constraints.

$PHRMed

Why Phreesia Stock Tumbled Today

Phreesia (PHR) shares fell 6.33% after reporting Q2 2027 revenue of $129.5M, up 10% YoY, and GAAP net income of $1.9M. While revenue beat estimates, earnings per share missed expectations. The company maintained full-year guidance and highlighted recent product launches.

$PHRLow

Phreesia Announces Second Quarter Fiscal 2027 Results

Phreesia, Inc. (PHR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Phreesia Announces Second Quarter Fiscal 2027 Results ALL-REMOTE COMPANY/WILMINGTON, Del., September 2, 2026 – Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal second quarter ended July 31, 2026. “Phreesia deli